Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"No discrete small-molecule-like molecular target" is a classification used in pharmacological databases like ChEMBL to describe drugs that do not interact with a specific protein, enzyme, or receptor (ChEMBL, 2024). Instead, these agents exert their therapeutic effects through broad physicochemical processes. For example, antacids like aluminum hydroxide neutralize gastric acid through direct chemical reaction, while osmotic laxatives such as polyethylene glycol and mannitol create an osmotic gradient to retain water in the intestinal tract (StatPearls, "Osmotic Diuretics"). Other examples include activated charcoal, which acts as an adsorbent to bind toxins, and surfactants like simethicone that reduce the surface tension of gas bubbles (NIH, PubChem). Because these substances lack a specific molecular binding site, they are typically administered in larger doses than targeted small molecules and do not follow traditional structure-activity relationship (SAR) models (Goodman & Gilman's The Pharmacological Basis of Therapeutics). While generally considered safe due to their lack of systemic receptor interaction, they can cause side effects such as electrolyte disturbances or interference with the absorption of concomitantly administered medications.
Physicochemical interaction (e.g., osmosis, neutralization, adsorption, or chelation) rather than binding to a specific biological macromolecule.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on No discrete small-molecule-like molecular target.